Approval · Notice of Compliance 8260 · 2006
MENJUGATE: Notice of Compliance 8260
Issued September 6, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8260
- Date
- September 6, 2006
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MENJUGATE | 02243820 | Cancelled Post Market |
Medicinal ingredients
- MENINGOCOCCAL C OLIGOSACCHARIDE 10 MCG per 0.5ML
- CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN 25 MCG per 0.5ML